Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 09, 2024 06:31 ET | Source: Sixty Degrees Pharmaceuticals

60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior Treatment

60 Degrees Pharma wins IRB approval for tafenoquine study for treating persistent babesiosis in immunocompromised patients despite prior treatment.
June 13, 2022 06:15 ET | Source: Global Market Insights Inc.

Clinical Trials Market worth 81.6 billion by 2030, says Global Market Insights Inc.

Selbyville, Delaware , June 13, 2022 (GLOBE NEWSWIRE) -- The clinical trials market value is expected to reach USD 81.6 billion by 2030, according to a new research report by Global Market...